| scholarly article | Q13442814 |
| P2093 | author name string | Kent R Bailey | |
| Claudio Cobelli | |||
| Adrian Vella | |||
| Chiara Dalla Man | |||
| Robert A Rizza | |||
| Marcello C Laurenti | |||
| Jon D Adams | |||
| M Daniela Hurtado Andrade | |||
| P2860 | cites work | Progressive change of intra-islet GLP-1 production during diabetes development | Q34021138 |
| The oral minimal model method | Q34263966 | ||
| Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells | Q34583696 | ||
| TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes | Q36562549 | ||
| Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo | Q39764273 | ||
| Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion. | Q42128258 | ||
| Impact of lack of suppression of glucagon on glucose tolerance in humans | Q42476091 | ||
| Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. | Q42536312 | ||
| Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations | Q43806842 | ||
| Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study | Q44686996 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans | Q47360675 | ||
| Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans | Q50734608 | ||
| Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation. | Q51280702 | ||
| Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. | Q51292373 | ||
| Association of fasting glucagon and proinsulin concentrations with insulin resistance. | Q51463725 | ||
| Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels? | Q58167548 | ||
| Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus | Q73234369 | ||
| Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597 | Q89278835 | ||
| P921 | main subject | glucagon | Q28163629 |
| P304 | page(s) | 154175 | |
| P577 | publication date | 2020-02-08 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Fasting glucagon concentrations are associated with longitudinal decline of β-cell function in non-diabetic humans | |
| P478 | volume | 105 |
| Q94493600 | The first Ramadan during COVID-19 pandemic: 1.8 billion Muslims should fast or not? | cites work | P2860 |
Search more.